Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 yearsCem Akin, Vito Sabato, Jason Gotlib, et al.
The Lancet. Haematology|January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling studyJavier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Cell Stem Cell|January 22, 2013
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibitionDaniel J Goff, Angela Court Recart, Anil Sadarangani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Blood Advances|January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER studyJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on MastocytosisJohannes Lübke, Juliana Schwaab, Deborah Christen, et al.
Hemasphere|December 13, 2021
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus ProposalPeter Valent, Cem Akin, Karin Hartmann, et al.
Pageof 28